Medifast, Inc.
MED
$13.40
$0.211.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 105.56M | 115.73M | 119.00M | 140.16M | 168.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 105.56M | 115.73M | 119.00M | 140.16M | 168.56M |
| Cost of Revenue | 28.91M | 31.48M | 30.78M | 34.49M | 45.12M |
| Gross Profit | 76.64M | 84.25M | 88.22M | 105.67M | 123.44M |
| SG&A Expenses | 76.61M | 84.51M | 86.21M | 102.47M | 130.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 106.62M | 116.99M | 118.29M | 138.06M | 176.43M |
| Operating Income | -1.07M | -1.26M | 709.00K | 2.11M | -7.88M |
| Income Before Tax | 2.88M | 526.00K | 1.28M | 1.58M | -10.65M |
| Income Tax Expenses | 395.00K | 1.30M | 474.00K | 449.00K | -2.50M |
| Earnings from Continuing Operations | 2.48M | -772.00K | 801.00K | 1.13M | -8.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.48M | -772.00K | 801.00K | 1.13M | -8.15M |
| EBIT | -1.07M | -1.26M | 709.00K | 2.11M | -7.88M |
| EBITDA | 2.98M | 2.02M | 13.08M | 2.22M | -4.81M |
| EPS Basic | 0.23 | -0.07 | 0.07 | 0.10 | -0.75 |
| Normalized Basic EPS | 0.16 | 0.03 | 0.07 | 0.09 | -0.61 |
| EPS Diluted | 0.22 | -0.07 | 0.07 | 0.10 | -0.75 |
| Normalized Diluted EPS | 0.16 | 0.03 | 0.07 | 0.09 | -0.61 |
| Average Basic Shares Outstanding | 10.99M | 10.95M | 10.94M | 10.94M | 10.94M |
| Average Diluted Shares Outstanding | 11.06M | 10.95M | 10.98M | 10.97M | 10.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.04% | -25.13% | 0.00% | 0.09% | -0.05% |